2.10 Pharmacotherapy Regimens and Predictors of Antipsychotic Use Among Youth Treated for Depression or Suicidality
Joseph C. Blader(State University of New York), Madhukar H. Trivedi(Southwestern Medical Center), Laura Stone, Emine Rabia Ayvaci, Abu Minhajuddin(Southwestern Medical Center), Sarah Wakefield(Texas Tech University), Blake M Upshaw, Eric A. Storch(University of Florida), John R Jeevarajan, Melissa DeFilippis(Freddie Mac (United States)), Vadym Zhyrov, Graham J. Emslie(Children's Medical Center)
Journal of the American Academy of Child & Adolescent Psychiatry
October 1, 2024
Cited by 0
Related Papers
The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation
|Psychological Medicine|2004|989
Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions
|World Psychiatry|2023|679
Efficacy of Paroxetine in the Treatment of Adolescent Major Depression: A Randomized, Controlled Trial
|Journal of the American Academy of Child & Adolescent Psychiatry|2001|648
Increased Rates of Bipolar Disorder Diagnoses Among U.S. Child, Adolescent, and Adult Inpatients, 1996–2004
|Biological Psychiatry|2007|355
Treatment of Autism Spectrum Disorder in Children and Adolescents
|Psychopharmacology Bulletin|2025|177